Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hepatitis Monthly is Scopus-indexed (Q4, CiteScore 0.7), WoS SCIE. Published by Brieflands.
Checked against the index lists dated .
ISSN 1735-143XVerify ISSN ↗1735-3408Verify ISSN ↗
Publisher: Brieflands
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 304 / 361 | 15th | Q4 |
| Hepatology | 76 / 88 | 14th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q4, CiteScore 0.7.
Hepatitis Monthly is Q4 in Infectious Diseases (rank 304 of 361) and Q4 in Hepatology (rank 76 of 88), by CiteScore 2025.
Hepatitis Monthly is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.7, which places it in quartile Q4 at the 15th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.181, quartile Q4, with an H-index of 50.
Hepatitis Monthly is published by Brieflands. Its print ISSN is 1735-143X and its online ISSN is 1735-3408.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Hepatitis Monthly has an h-index of 53 and a 2-year mean of 0.55 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #273 of 354 Scopus journals in Infectious Diseases.
Hepatitis Monthly published 51 papers in 2025; its busiest recent year was 2017 with 84. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2024–2026), authors are most often from China (58.6%), Iran (24.7%) and Türkiye (12.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.